UK pushes vet pricing transparency and broader sector reform

The UK is reshaping companion-animal veterinary regulation on two tracks at once: the Competition and Markets Authority has concluded its long-running market investigation with a binding remedies package aimed at lowering friction on prices and choice, and Defra has launched a consultation on wider legislative reform that it calls the biggest overhaul of the sector in 60 years. Together, the moves are designed to address rising pet care costs, which the government said had increased at nearly twice the rate of inflation, and to modernize a regulatory framework built around a 1966 law written long before today’s corporate practice landscape. (gov.uk)

The immediate trigger was the CMA’s review of the UK pet-vet market, which began with a call for information in September 2023, escalated to a formal market investigation in May 2024, and drew unusually broad engagement across the sector. According to the CMA, the process included 56,000 responses, among them roughly 11,000 from veterinary professionals, and focused on concerns that pet parents often lacked usable pricing information, didn’t always realize when a clinic was part of a larger chain, and faced limited transparency around medicines, care plans, and cremation services. The CMA has also noted that the six largest veterinary groups account for a substantial share of the market. (gov.uk)

The final remedies are operationally specific. Practices will have to publish comprehensive price lists for standard services, including consultations, common procedures, diagnostics, written prescriptions, and cremation options. Price and ownership data will also feed into the Royal College of Veterinary Surgeons’ “Find a Vet” service for sharing with comparison sites. Clinics must disclose whether they are independent or part of a group, including on signage and online. For non-emergency treatment expected to cost £500 or more, practices will need to provide written estimates in advance and then an itemized bill. The CMA also capped written prescription fees at £21 for the first medicine and £12.50 for each additional medicine, and said practices must tell pet parents they can request a written prescription and may save money by purchasing long-term medication elsewhere. (gov.uk)

Defra’s parallel reform agenda goes further than pricing. In its January 27, 2026 announcement, the department said proposed changes to the Veterinary Surgeons Act would create a more modern governance model for the RCVS, bring veterinary nurses and certain allied veterinary professionals into regulation, and introduce a licensing system for veterinary businesses. The government has argued that stronger oversight of businesses, not just individual vets, is needed because the current framework predates modern ownership structures and no longer matches how care is delivered. (gov.uk)

Reaction from the profession has been supportive in principle, but cautious on implementation. The RCVS said it welcomed the market investigation as an opportunity to improve consumer protection and recognized the high trust placed in veterinary professionals. In a joint response to the CMA’s provisional decision, BVA, BSAVA, BVNA, SPVS, and VMG said they could support many of the transparency and complaints-related remedies, as well as legislative reform and practice regulation, but warned that some medicine-market proposals were disproportionate and could disadvantage practices without online pharmacy capability. Consumer group Which? was more forceful, saying business oversight is urgently needed and arguing that any new licensing system should carry meaningful sanctions. (rcvs.org.uk)

Why it matters: For veterinary professionals, the UK changes are important because they treat affordability and transparency as regulatory issues, not just communication issues. That has practical implications for workflow, estimate generation, website management, prescribing conversations, fee architecture, and documentation of clinical independence. It also signals a policy shift toward regulating veterinary businesses as market actors, especially in corporate settings, rather than relying mainly on professional regulation of individual clinicians. For US readers, the details may differ, but the underlying pressure points, consolidation, client price sensitivity, pharmacy competition, and scrutiny of transparency, will feel familiar. (gov.uk)

There’s also a tension the UK will have to manage carefully. Policymakers are trying to improve consumer choice and lower avoidable costs without undermining smaller practices, reducing service viability, or pushing teams into box-checking compliance that adds administrative drag. The profession’s mixed reaction suggests the success of the reforms will hinge less on whether transparency is desirable, which is widely accepted, and more on how implementation is sequenced, funded, and enforced. That will matter for independent clinics, rural access, and the economics of dispensing and ancillary services. (bsava.com)

What to watch: The next key markers are the CMA’s remedies timetable and Defra’s response to its consultation on Veterinary Surgeons Act reform, including whether business licensing, expanded professional regulation, and governance changes move into legislation on a near-term schedule. If they do, the UK could become a closely watched model for how governments respond when veterinary affordability, transparency, and consolidation become politically salient at the same time. (gov.uk)